145 related articles for article (PubMed ID: 17496795)
1. Reduced signal of locus ceruleus in depression in quantitative neuromelanin magnetic resonance imaging.
Shibata E; Sasaki M; Tohyama K; Otsuka K; Sakai A
Neuroreport; 2007 Mar; 18(5):415-8. PubMed ID: 17496795
[TBL] [Abstract][Full Text] [Related]
2. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
3. Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus.
Shibata E; Sasaki M; Tohyama K; Otsuka K; Endoh J; Terayama Y; Sakai A
Biol Psychiatry; 2008 Sep; 64(5):401-6. PubMed ID: 18452894
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla.
Shibata E; Sasaki M; Tohyama K; Kanbara Y; Otsuka K; Ehara S; Sakai A
Magn Reson Med Sci; 2006 Dec; 5(4):197-200. PubMed ID: 17332710
[TBL] [Abstract][Full Text] [Related]
5. The neuropathology of aminergic nuclei in Alzheimer's disease.
Zweig RM; Ross CA; Hedreen JC; Steele C; Cardillo JE; Whitehouse PJ; Folstein MF; Price DL
Ann Neurol; 1988 Aug; 24(2):233-42. PubMed ID: 3178178
[TBL] [Abstract][Full Text] [Related]
6. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging.
Ohtsuka C; Sasaki M; Konno K; Koide M; Kato K; Takahashi J; Takahashi S; Kudo K; Yamashita F; Terayama Y
Neurosci Lett; 2013 Apr; 541():93-8. PubMed ID: 23428505
[TBL] [Abstract][Full Text] [Related]
7. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
[TBL] [Abstract][Full Text] [Related]
8. Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications.
Sasaki M; Shibata E; Tohyama K; Kudo K; Endoh J; Otsuka K; Sakai A
Neuroreport; 2008 Nov; 19(17):1649-54. PubMed ID: 18852680
[TBL] [Abstract][Full Text] [Related]
9. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging.
Ohtsuka C; Sasaki M; Konno K; Kato K; Takahashi J; Yamashita F; Terayama Y
Parkinsonism Relat Disord; 2014 Jul; 20(7):755-60. PubMed ID: 24768616
[TBL] [Abstract][Full Text] [Related]
11. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy.
Miyoshi F; Ogawa T; Kitao SI; Kitayama M; Shinohara Y; Takasugi M; Fujii S; Kaminou T
AJNR Am J Neuroradiol; 2013; 34(11):2113-8. PubMed ID: 23744697
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease.
Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
J Parkinsons Dis; 2015; 5(3):561-7. PubMed ID: 26406136
[TBL] [Abstract][Full Text] [Related]
14. Visualization of neuromelanin in the Substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast.
Nakane T; Nihashi T; Kawai H; Naganawa S
Magn Reson Med Sci; 2008; 7(4):205-10. PubMed ID: 19110515
[TBL] [Abstract][Full Text] [Related]
15. Neuromelanin, neuroleptics and schizophrenia: hypothesis of an interaction between noradrenergic and dopaminergic system.
Kaiya H
Neuropsychobiology; 1980; 6(5):241-8. PubMed ID: 6106167
[TBL] [Abstract][Full Text] [Related]
16. Neuromelanin Locus Coeruleus MRI Contrast in Migraine With Aura.
Gollion C; Arribarat G; Ruidavets JB; Fabre N; Barège M; Bonneville F; Larrue V; Peran P
Headache; 2020 Apr; 60(4):752-760. PubMed ID: 32065391
[TBL] [Abstract][Full Text] [Related]
17. Depression in the elderly: pathological study of raphe and locus ceruleus.
Syed A; Chatfield M; Matthews F; Harrison P; Brayne C; Esiri MM
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):405-13. PubMed ID: 16008824
[TBL] [Abstract][Full Text] [Related]
18. Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.
Watanabe Y; Tanaka H; Tsukabe A; Kunitomi Y; Nishizawa M; Hashimoto R; Yamamori H; Fujimoto M; Fukunaga M; Tomiyama N
PLoS One; 2014; 9(8):e104619. PubMed ID: 25111500
[TBL] [Abstract][Full Text] [Related]
19. In vivo MRI assessment of the human locus coeruleus along its rostrocaudal extent in young and older adults.
Betts MJ; Cardenas-Blanco A; Kanowski M; Jessen F; Düzel E
Neuroimage; 2017 Dec; 163():150-159. PubMed ID: 28943414
[TBL] [Abstract][Full Text] [Related]
20. [Clinical applications of 3.0 T magnetic resonance system in the neuroradiological field].
Matsusue E; Ogawa T
Brain Nerve; 2007 May; 59(5):479-85. PubMed ID: 17533973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
